Efficacy and safety of integrating consolidative thoracic radiotherapy with immunochemotherapy in ES-SCLC: A real-world retrospective analysis

被引:0
|
作者
Zhang, Q. [1 ]
Liu, C. [2 ]
Wu, X. [3 ]
Zheng, C. [4 ]
Wang, Y. [5 ]
机构
[1] Shandong First Med Univ, Shandong Canc Hosp, Chest Radiotherapy Wards 5, Jinan, Peoples R China
[2] Shandong Univ, Shandong Canc Hosp, Radiotherapy, Jinan, Peoples R China
[3] Southwest Med Univ, Coll Clin Med, Med Clin, Luzhou, Peoples R China
[4] Shandong First Med Univ & Shandong Acad Med Sci, Clin Med, Jinan, Peoples R China
[5] Shandong First Med Univ, Shandong Prov Hosp, Dept Ultrasound Med, Ultrasound Med, Jinan, Peoples R China
关键词
D O I
10.1016/j.annonc.2024.08.1890
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1799P
引用
收藏
页码:S1069 / S1069
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of integrating consolidative thoracic radiotherapy with immunochemotherapy in extensive-stage small cell lung cancer: a real-world retrospective analysis
    Zhang, Qi
    Wang, Qian
    Wang, Mengsen
    Liu, Xiaomeng
    Han, Dan
    Sun, Hongfu
    Zhao, Chengwei
    Liu, Chengxin
    JOURNAL OF THORACIC DISEASE, 2025, 17 (02)
  • [2] Consolidative intrathoracic radiotherapy during maintenance first-line immunotherapy in extensive stage small cell lung cancer (ES-SCLC): A retrospective multicenter analysis of safety and efficacy
    Bruni, A.
    Bertolini, F.
    Borghetti, P.
    Scotti, V.
    Sepulcri, M.
    Pasello, G.
    Giaj-Levra, N.
    Grisanti, S.
    Katica, M.
    Cappelli, A.
    Garlatti, P.
    Guaitoli, G.
    Dominici, M.
    Lohr, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S1068 - S1068
  • [3] Efficacy and safety of lurbinectedin in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC): A multicenter, retrospective real-world study
    Xiang, Y.
    Tang, Y.
    Luan, T.
    Mengchen, L.
    Shi, W.
    Chin, A. G. W.
    Feng, X.
    Wang, F.
    Sun, X. W.
    Bao, Z.
    Zhou, J.
    Zhao, J.
    Wu, H.
    Fu, D.
    ANNALS OF ONCOLOGY, 2024, 35 : S1666 - S1667
  • [4] Real-world analysis of ICI efficacy in ES-SCLC patients with and without brain metastases: A call for inclusion in clinical trials
    Cao, Yuanzhen
    Afzal, Muhammad Zubair
    Lu, Ziyao
    Sharma, Aditya
    Pirruccello, Jonathan P.
    Shirai, Keisuke
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Real-World Analysis of ICI Efficacy in ES-SCLC Patients with and without Brain Metastases: A Call for Inclusion in Clinical Trials
    Cao, Y.
    Afzal, M. Z.
    Lu, Z.
    Sharma, A.
    Pirruccello, J.
    Shirai, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S692 - S693
  • [6] Real-world data of consolidative radiotherapy for extensive stage (ES)-SCLC treated by chemo-immunotherapy (chemo-IO)
    Daher, S. N.
    Allen, A.
    Rottenberg, Y.
    Nasrallah, H.
    Yosef, L.
    Blumenfeld, P.
    Wollner, M.
    Appel, S.
    Nechushtan, H.
    Moskovitz, M.
    Bar, J.
    Zer, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S99 - S100
  • [7] First line CT-IT followed by thoracic RT in ES-SCLC:a retrospective multicenter study on safety
    Bruni, Alessio
    Bertolini, Federica
    Scotti, Vieri
    Borghetti, Paolo
    Sepulcri, Matteo
    Katica, Mirsada
    Imbrescia, Jessica
    Levra, Niccolo Giaj
    Grisanti, Salvatore
    Benini, Anna
    Cappelli, Anna
    Garlatti, Pietro
    Guaitoli, Giorgia
    Dominici, Massimo
    Lohr, Frank
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1699 - S1700
  • [8] Quantitative Volumetric Disease Burden Response to Predict Benefit of Consolidative Thoracic Radiotherapy in Extensive Stage Small Cell Lung Cancer (ES-SCLC)
    Anderson, J. L.
    Anderson, C. E.
    Xu, M. C.
    Osmundson, E. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E546 - E546
  • [9] Immune activation effect and survival of different irradiated sites in ES-SCLC patients treated with radioimmunotherapy: A real-world analysis
    Wu, M.
    Zhou, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1069 - S1069
  • [10] Immune Activation Effect of Different Irradiated Sites and Survival in ES-SCLC Patients Treated with Radioimmunotherapy: A Real-World Analysis
    Wu, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S707 - S708